Vanguard Group’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.33B Buy
16,719,886
+1,056,792
+7% +$69.3M 0.02% 604
2025
Q3
$731M Sell
15,663,094
-98,597
-0.6% -$3.86M 0.01% 847
2025
Q2
$580M Sell
15,761,691
-850,344
-5% -$32.7M 0.01% 945
2025
Q1
$587M Sell
16,612,035
-484,420
-3% -$19.7M 0.01% 901
2024
Q4
$748M Buy
17,096,455
+2,185,082
+15% +$110M 0.01% 815
2024
Q3
$676M Buy
14,911,373
+533,076
+4% +$23.2M 0.01% 863
2024
Q2
$558M Sell
14,378,297
-378,815
-3% -$14.2M 0.01% 921
2024
Q1
$476M Buy
14,757,112
+122,721
+0.8% +$3.64M 0.01% 1024
2023
Q4
$420M Buy
14,634,391
+4,990,800
+52% +$120M 0.01% 1073
2023
Q3
$267M Buy
9,643,591
+303,088
+3% +$8.99M 0.01% 1282
2023
Q2
$250M Buy
9,340,503
+37,950
+0.4% +$931K 0.01% 1344
2023
Q1
$201M Buy
9,302,553
+1,740,643
+23% +$42.9M 0.01% 1453
2022
Q4
$180M Buy
7,561,910
+577,908
+8% +$12.3M ﹤0.01% 1487
2022
Q3
$138M Buy
6,984,002
+1,416,990
+25% +$31.1M ﹤0.01% 1609
2022
Q2
$109M Sell
5,567,012
-490,919
-8% -$9.56M ﹤0.01% 1768
2022
Q1
$155M Sell
6,057,931
-241,678
-4% -$5.26M ﹤0.01% 1710
2021
Q4
$159M Buy
6,299,609
+59,411
+1% +$1.67M ﹤0.01% 1731
2021
Q3
$172M Buy
6,240,198
+971,634
+18% +$28.3M ﹤0.01% 1693
2021
Q2
$167M Buy
5,268,564
+418,302
+9% +$14.6M ﹤0.01% 1729
2021
Q1
$223M Buy
4,850,262
+812,442
+20% +$36.4M 0.01% 1527
2020
Q4
$160M Buy
4,037,820
+587,719
+17% +$23.2M ﹤0.01% 1592
2020
Q3
$120M Buy
3,450,101
+2,131,334
+162% +$59M ﹤0.01% 1594
2020
Q2
$41.6M Buy
1,318,767
+229,117
+21% +$7.2M ﹤0.01% 2092
2020
Q1
$23.9M Buy
+1,089,650
New +$30.2M ﹤0.01% 2201

Other funds holding RVMD